4//SEC Filing
Stolarski Anthony Michael 4
Accession 0001437749-25-020194
CIK 0001417663other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:18 PM ET
Size
74.8 KB
Accession
0001437749-25-020194
Insider Transaction Report
Form 4
Stolarski Anthony Michael
Director
Transactions
- Award
Class O Warrant (right to buy)
2019-03-01+533→ 533 totalExercise: $41.25From: 2019-03-01Exp: 2019-06-28→ Common Stock (533 underlying) - Award
Class O Warrant (right to buy)
2019-05-31+533→ 533 totalExercise: $41.25From: 2019-05-31Exp: 2019-09-03→ Common Stock (533 underlying) - Award
Future Advance Convertible Promissory Note
2022-08-05$1344966.00/shExercise: $15.00From: 2022-08-05Exp: 2023-08-05→ Common Stock (89,664 underlying) - Award
Common Stock Purchase Warrant (right to buy)
2022-08-05+89,664→ 89,664 totalExercise: $25.13From: 2022-08-05Exp: 2027-08-05→ Common Stock (89,664 underlying) - Award
Common Stock Purchase Warrant (right to buy)
2024-01-21+9,999→ 9,999 totalExercise: $15.00From: 2024-01-21Exp: 2029-01-21→ Common Stock (9,999 underlying) - Disposition to Issuer
Common Stock Purchase Warrant (right to buy)
2024-10-18−9,999→ 0 totalExercise: $25.13From: 2024-01-21Exp: 2029-01-21→ Common Stock (9,999 underlying) - Award
Stock Option (right to buy)
2024-12-31+1,559→ 1,559 totalExercise: $22.76Exp: 2029-12-31→ Common Stock (1,559 underlying) - Conversion
Common Stock
2023-11-14$15.00/sh+6,900$103,500→ 155,373 total - Disposition to Issuer
Common Stock Purchase Warrant (right to buy)
2024-10-18−89,664→ 0 totalExercise: $15.00From: 2022-08-05Exp: 2027-08-05→ Common Stock (89,664 underlying) - Award
Common Stock
2024-10-18+76,215→ 312,286 total - Award
Common Stock
2024-10-18+5,100→ 322,786 total - Disposition to Issuer
Class O Warrant (right to buy)
2019-03-01−533→ 0 totalExercise: $41.25From: 2017-12-11Exp: 2019-03-17→ Common Stock (533 underlying) - Award
Common Stock Purchase Warrant (right to buy)
2022-11-14+6,000→ 6,000 totalExercise: $15.00From: 2022-11-14Exp: 2027-11-14→ Common Stock (6,000 underlying) - Disposition to Issuer
Common Stock Purchase Warrant (right to buy)
2024-10-18−6,000→ 0 totalExercise: $15.00From: 2022-11-14Exp: 2027-11-14→ Common Stock (6,000 underlying) - Award
Common Stock Purchase Warrant (right to buy)
2022-11-14+6,000→ 6,000 totalExercise: $25.13From: 2022-11-14Exp: 2027-11-14→ Common Stock (6,000 underlying) - Disposition to Issuer
Common Stock Purchase Warrant (right to buy)
2024-10-18−6,000→ 0 totalExercise: $25.13From: 2022-11-14Exp: 2027-11-14→ Common Stock (6,000 underlying) - Disposition to Issuer
Future Advance Convertible Promissory Note
2024-10-18→ 0 totalExercise: $15.00From: 2024-01-21Exp: 2025-01-21→ Common Stock (11,500 underlying) - Disposition to Issuer
Common Stock Purchase Warrant (right to buy)
2024-10-18−9,999→ 0 totalExercise: $15.00From: 2024-01-21Exp: 2029-01-21→ Common Stock (9,999 underlying) - Award
Common Stock
2024-10-18+80,698→ 236,071 total - Award
Common Stock
2024-10-18+11,500→ 334,286 total - Award
Common Stock
2024-10-18+9,000→ 343,286 total - Award
Common Stock
2024-10-18+8,500→ 351,786 total - Conversion
Common Stock
2023-08-05$15.00/sh+103,114$1,546,710→ 148,473 total - Award
Future Advance Convertible Promissory Note
2022-11-14$90000.00/shExercise: $15.00From: 2022-11-14Exp: 2023-11-14→ Common Stock (6,000 underlying) - Conversion
Future Advance Convertible Promissory Note
2023-11-14→ 0 totalExercise: $15.00From: 2022-11-14Exp: 2023-11-14→ Common Stock (6,900 underlying) - Disposition to Issuer
Asset-Backed Secured Promissory Note
2024-01-21Exp: 2024-01-21→ Common Stock - Award
Future Advance Convertible Promissory Note
2024-01-21$149992.50/shExercise: $15.00From: 2024-01-21Exp: 2025-01-21→ Common Stock (9,999 underlying) - Award
Common Stock Purchase Warrant (right to buy)
2024-01-21+9,999→ 9,999 totalExercise: $25.13From: 2024-01-21Exp: 2029-01-21→ Common Stock (9,999 underlying) - Award
Stock Option (right to buy)
2024-10-22+41,333→ 41,333 totalExercise: $14.20Exp: 2034-10-22→ Common Stock (41,333 underlying) - Award
Stock Option (right to buy)
2025-04-03+1,761→ 1,761 totalExercise: $29.80Exp: 2030-04-03→ Common Stock (1,761 underlying) - Award
Common Stock
2024-10-18+5,400→ 317,686 total - Disposition to Issuer
Class O Warrant (right to buy)
2019-05-31−533→ 0 totalExercise: $41.25From: 2019-03-01Exp: 2019-06-28→ Common Stock (533 underlying) - Conversion
Future Advance Convertible Promissory Note
2023-08-05→ 0 totalExercise: $15.00From: 2022-08-05Exp: 2023-08-05→ Common Stock (103,114 underlying) - Award
Common Stock Purchase Warrant (right to buy)
2022-08-05+89,664→ 89,664 totalExercise: $15.00From: 2022-08-05Exp: 2027-08-05→ Common Stock (89,664 underlying) - Award
Asset-Backed Secured Promissory Note
2023-07-21$100000.00/shExp: 2024-01-21→ Common Stock - Disposition to Issuer
Common Stock Purchase Warrant (right to buy)
2024-10-18−89,664→ 0 totalExercise: $25.13From: 2022-08-05Exp: 2027-08-05→ Common Stock (89,664 underlying)
Footnotes (10)
- [F1]Pursuant to the terms of the Future Advance Convertible Promissory Note issued by SANUWAVE Health, Inc. (the "Company") on August 5, 2022, all principal and accrued interest due as of the maturity date, August 5, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share.
- [F10]Options were fully vested at the grant date.
- [F2]Pursuant to the terms of the Future Advance Convertible Promissory Note issued by the Company on November 14, 2022, all principal and accrued interest due as of the maturity date, November 14, 2023, was automatically converted into shares of common stock at a conversion price of $15.00 per share.
- [F3]On October 18, 2024, effective upon the Company's 1-for-375 reverse stock split, the reporting person's outstanding Future Advance Convertible Promissory Note and Common Stock Purchase Warrants were exchanged for an aggregate of 196,413 shares of common stock pursuant to a letter agreement between the reporting person and the Company.
- [F4]On March 1, 2019, the Company extended the expiration date of the Class O Warrants to June 28, 2019.
- [F5]On May 31, 2019, the Company extended the expiration date of the Class O Warrants to September 3, 2019.
- [F6]On August 5, 2022, in exchange for the discharge of $1,344,966 owed by the Company to the reporting person, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $1,344,966 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 89,664 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 89,664 shares of common stock at an exercise price of approximately $25.13 per share).
- [F7]On November 14, 2022, in exchange for $90,000 in cash, the reporting person acquired from the Company a Future Advance Convertible Promissory Note with a principal amount of $90,000 and a conversion price of $15.00 per share of common stock and two warrants (one exercisable for 6,000 shares of common stock at an exercise price of $15.00 per share and the other exercisable for 6,000 shares of common stock at an exercise price of approximately $25.13 per share).
- [F8]On July 21, 2023, in exchange for $100,000 in cash, the reporting person acquired from the Company an Asset-Backed Secured Promissory Note with a principal amount of $149,992.50. Pursuant to a letter agreement between the Company and the reporting person, dated as of July 21, 2023, the Company agreed to issue to the reporting person on January 21, 2024 a Future Advance Convertible Promissory Note with a principal amount of $149,992.50 and two Common Stock Purchase Warrants, one with an exercise price of $15.00 per share and one with an exercise price of $25.13 per share, each of which were exercisable for 9,999 shares of common stock.
- [F9]Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.
Documents
Issuer
SANUWAVE Health, Inc.
CIK 0001417663
Entity typeother
Related Parties
1- filerCIK 0001683425
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:18 PM ET
- Size
- 74.8 KB